Company profile: Peloton Therapeutics
1.1 - Company Overview
Company description
- Provider of cancer drug discovery and development based in Dallas. Offers a clinical-stage small-molecule HIF-2α inhibitor targeting hypoxia-inducible factor-2α for kidney cancer and other disorders, and research programs to discover compounds that modulate disease-driving protein-protein interactions.
Products and services
- HIF-2α Inhibitor: A clinical-stage small-molecule product that targets hypoxia-inducible factor‑2α, a transcription factor involved in kidney cancer and other disorders, directly inhibiting this protein
- Cancer Drug Discovery and Development: Oncology-focused programs that discover and develop novel drugs for cancer treatments, advancing Peloton’s Dallas-based research toward novel cancer therapeutics
- Research Programs: Protein–protein interaction–focused initiatives that engineer new compounds to modulate disease-driving interactions, building on the success of inhibiting HIF‑2α.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Peloton Therapeutics
Univercells Technologies
HQ: Belgium
Website
- Description: Provider of biomanufacturing services and platforms for cost-effective viral production from R&D to commercial scale, offering scale-X bioreactors (hydro, carbo) for adherent and suspension cells, the scale-X cell collect system, and the NevoLine Upstream platform integrating virus production, concentration, and clarification, plus services including equipment confirmation, capacity and facility design, and bioprocess excellence.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Univercells Technologies company profile →
BioLegend
HQ: United States
Website
- Description: Provider of immunological reagents for biomedical research, developing antibodies, recombinant proteins, bioassays, and other research reagents at a state-of-the-art facility in San Diego, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLegend company profile →
Incept Biosystems
HQ: United States
Website
- Description: Provider of innovative microscale technologies that provide fertility specialists breakthrough capabilities to treat infertility, improving the in vitro manipulation, performance, and viability of high-value cells, with a mission to set the standard for next-generation clinical devices for Assisted Reproductive.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Incept Biosystems company profile →
Gemini Bio
HQ: United States
Website
- Description: Provider of FDA-registered biological products and chemical reagents for the global cell culture community, offering cell culture sera (fetal bovine and other human/animal), custom and specialized media and buffers, supplements and reagents (amino acids, antibiotics, antimycotics), high purity water including WFI-quality, and cGMP contract manufacturing/private-label process liquids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemini Bio company profile →
Savsu
HQ: United States
Website
- Description: Provider of integrated, innovative hardware and software solutions designed to protect live cell therapies during transport and storage, serving cell and gene therapy companies, specialty couriers, biotech/biopharma, research institutions, governments, and NGOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Savsu company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Peloton Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Peloton Therapeutics
2.2 - Growth funds investing in similar companies to Peloton Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Peloton Therapeutics
4.2 - Public trading comparable groups for Peloton Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →